// App-Quantinova.ai

OA0015 : Final results from the ZENITH‐1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema

Researchers

Presenter

  • Longhurst HJ

Principal Investigators

  • Zanichelli A

  • Huissoon A

  • Moldovan D

  • Maurer M

  • Magerl M

  • Cancian M

  • Senter R

  • Manson A

  • Aygren-Prsn E

  • Grivcheva-Panovska V

  • Hagin D

  • Steiner U

  • Kiani-Alikhan S

  • Agmon-Levin N

  • Bygum A

  • Aberer W

  • Faust S. N

  • Launay D

  • Gompels M

  • Triggiani M

  • Bethune C

  • Reshef A

  • Cornpropst M

  • Dobo S

  • Van Dyke S

  • Murray S

  • Collis P

  • Sheridan WP

  • Farkas H

  • Cicardi M

Medical Centers

  • Addenbrookes Hospital, Cambridge, United Kingdom

  • Jagiellonian University Medical College, Cracow, Poland

  • Derriford Hospital, Plymouth, United Kingdom

  • Luigi Sacco Hospital, Milano, Italy

  • Birmingham Children's Hospital, Birmingham, United Kingdom

  • Centrul Medical Mediquest, Sangeorgiul De Mures, Romania

  • Charite Univsmedizin Berlin, Berlin, Germany

  • University of Pavia, Pavia, Italy

  • University Hospital Frankfurt, Goethe University, Frankfurt, Germany

  • University Sts. Cyril and Methodius, Skopje, Macedonia, Former Republic of Yugoslav

  • Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel

  • The Royal Marsden Hospital, London, United Kingdom

  • Sheba Medical Center, Ramat-Gan, Ireland

  • Odense University Hospital, Odense, Denmark

  • Medical University Graz, Graz, Austria

  • Southampton General Hospital, Southampton, United Kingdom

  • Claude Huriez Hospital, Lille, France

  • Southmead Hospital, Bristol, United Kingdom

  • University of Palermo, Palermo, Italy

  • Barzilai Medical Center, Ashkelon, Israel

  • Dova Pharmaceuticals, Durham, United States

  • Semmelweis University, Budapest, Hungary

Locations

  • United Kingdom

  • Poland

  • Italy

  • Romania

  • Germany

  • Republic of South Korea

  • Israel

  • Switzerland

  • Denmark

  • Austria

  • France

  • United States

  • Hungary

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Hereditary angioedema

Biomarkers

  • N/A

Drug/Treatment

  • BCX7353

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved